Ιούλ 19, 2022 | Medical News, Scientific articles, Επιστημονικά Άρθρα, Κλ. Μελέτες - Έρευνες
Background: The adaptation of the right ventricular contractility to its afterload (RV–PA coupling), best measured by the ratio of end-systolic elastance (Ees) and arterial elastance (Ea), is a key determinant for prognosis and symptomatology in pulmonary hypertension...
Ιούλ 19, 2022 | Medical News, Scientific articles, Επιστημονικά Άρθρα, Κλ. Μελέτες - Έρευνες
PULSAR open-label extension: Long-term efficacy and safety of sotatercept for the treatment of pulmonary arterial hypertension (PAH) Pulmonary arterial hypertension (PAH) is a progressive disease driven by pulmonary vascular remodeling. Sotatercept acts as a...Νοέ 30, 2017 | Scientific articles
BY WENDY HENDERSON Pulmonary hypertension (PH) is a chronic lung disease where the blood pressure in the lungs is dangerously elevated. This leads to the right side of the heart having to work much harder to pump oxygenated blood back into the lungs and can lead to...Οκτ 5, 2017 | Announcements, Scientific articles
Abstract Background: Vitamin D (Vit D) is linked to various conditions including musculoskeletal, metabolic and cardiopulmonary diseases. However, it is not clear whether correction of vit D deficiency exerts any beneficial effect in patients with pulmonary...Απρ 4, 2017 | Scientific articles
A significant proportion of patients with hyperthyroidism may have mild pulmonary hypertension (PH), according to the results of a recent study. Increased pulmonary vascular resistance may be the underlying cause of this association. The study, “Relationship Among...Μαρ 6, 2017 | Scientific articles
Professor Daniel Chambers from the Queensland Lung Transplant Service, at The Prince Charles Hospital in Brisbane, Australia, debunks 10 myths about lung transplants for pulmonary hypertension patients and other patients with lung problems. Read about five of the...
Join our mailing list to receive the latest news and updates from our team.